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COMMISSION STAFF WORKING DOCUMENT 
Implementation of the second Programme of Community action in the field of health in 2012 
This document is a European Commission staff working document for information purposes. It does not represent an 
official position of the Commission on this issue, nor does it anticipate such a position. 
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Introduction 
The second Health Programme established by Decision 1350/2007/EC of the European Parliament 
and of the Council of 23 October 2007 came into force on 1 January 2008 and ended on 31 December 
2013. The Programme was allocated a total budget of € 321.5 million and its purpose was to finance 
actions that complement, support and add value to national health policies across Europe. It is built 
around three main objectives:  
Objective 1: Improve citizens’ health security 
Objective 2: Promote health and reduce health inequalities 
Objective 3: Generate and disseminate health information and health knowledge.  
As per Article 13(1) of the Programme Decision, the Commission shall report annually to the Health 
Programme Committee on all actions and projects funded through the Programme and keep the 
European Parliament and the Council informed. The purpose of this working document is to meet this 
requirement. 
It consists of two parts:  
The first part (pp. 3-17) presents briefly a set of examples of key outcomes of actions funded under the 
Programme mainly in years 2008 and 2009 which have been achieved in 2012 and which delivered 
substantial results that year. 
The second part (pp. 18-43) provides detailed information on the budget for 2012 and its execution. 
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1st Part : Key results of actions funded under the second  
Health Programme 
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1 EXAMPLES OF PROGRAMME OUTPUTS 
This section of the report highlights examples of activities which were finalised 
during 2012. These cover the three strands of action of the programme – health 
security, health promotion and health information.  
2 HEALTH SECURITY 
2.1 Harm reduction – Scaling up access to high quality harm reduction,  
  treatment and care for injecting drug users in the European Union: 
2.1.1 Background information 
The Direct Grant agreement with WHO was funded under the 2008 work plan of the second Health 
Programme 2003-2008, with the funding from the EU totalling EUR 299.109. It started in December 
2009 and ended in June 2012.  
2.1.2 Brief description 
The overall aim of this project was to develop a strategy for improving the accessibility and quality of 
harm reduction services in the EU and WHO European Region. This concerned in particular HIV 
treatment, integrated HIV-TB services, hepatitis C treatment and opioid substitution treatment for 
injecting drug users (IDUs) in Europe.  In addition, training on the delivery of high-quality harm 
reduction services in the WHO European Region was developed and the formation of policies 
supporting such services was promoted. 
 
By looking at how harm reduction services for treatment and care for injecting drug users can be 
improved, this project also contributed to the implementation of the Commission communication on 
combating HIV/AIDS in the European Union and the neighbouring countries 2009-2013. The work 
was carried out by the WHO Regional Office for Europe with the Centre for  Research on Drugs and 
Health Behaviour at the London School of Hygiene and Tropical Medicine and the Eurasian Harm 
Reduction Network.  
2.1.3 Concrete outcomes 
The key output of this project was the production of proposals towards WHO European Action Plan 
for HIV/AIDS 2012-2015, which has been adopted by 53 countries of the European region. In 
addition, a set of recommendations on indicators of quality and delivery for hepatitis C treatment were 
prepared together with guidance on how to scale-up and implement opioid substitution treatment. In 
addition, a training module on tuberculosis prevention and on the treatment and care of drug-users was 
developed. 
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 Finally, a policy briefing on developing integrated models of tuberculosis-HIV services and 
on barriers and facilitators to hepatitis C treatment for injecting drug users was prepared. 
All these deliverables can be found at: http://www.euro.who.int/en/what-we-do/health-
topics/communicable-diseases/hivaids/activities/ec-who-project-scaling-up-access-to-high-quality-
harm-reduction/ec-who-grant-agreement-on-harm-reduction 
 
2.2 ELIPSY: EUROPEAN LIVING DONOR PSYCHOSOCIAL FOLLOW- UP 
2.2.1 Background 
The project was funded under the 2008 work plan of the second Health Programme 2008-2013, with 
the funding from the EU totalling EUR 299.128,25. It started in December 2009 and ended in 
November 2012. 
2.2.2 Brief description 
The objective was to contribute to a high quality of living organ donation by creating a follow-up 
model for the living donors' psychosocial well-being and quality of life, and to promote its use in 
living donor transplantation programmes in the EU Member States. The transplant centres with living 
donations need to include the psychosocial assessment of each living donor in their protocols to 
uncover any coercion to donate and any psychological or social problems that could have an impact on 
the selection for donors. The study was a multicentre study developed in six European centres and 
countries. 
2.2.3 Concrete outcomes 
The study identified the most relevant variables to be assessed in an evaluation procedure during the 
living donor psychosocial follow-up. The quality of life scores fell within the normal range compared 
to the general population. The ELIPSY module can be directly used by health professionals in 
transplant centres with living donation programmes.  
Finally, the ELIPSY module makes a substantial contribution to the new Joint Action ACCORD as 
regards living donation registries. Therefore, the project provides useful information for the competent 
authorities in the Member States and guide the development of future EU policies in this field. 
More information: http://ec.europa.eu/eahc/projects/database.html?prjno=20081104 
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 3  HEALTH PROMOTION 
3.1 EURHOBOP: European Hospital Benchmarking by Outcomes in Acute 
Coronary Syndrome and Orthopaedic Procedures 
3.1.1 Background information 
The project was funded under the 2008 work plan of the second Health Programme 2008-2013, with 
funding from the EU totalling EUR 1.146.581. It started in September 2009 and ended in August 
2012. 
3.1.2 Brief description 
The aim of the project was to set up a validated methodology to benchmark the quality of care of 
patients suffering from coronary heart disease (CHD) in Europe. The prevalence of CHD is 3-10% in 
the European adult population and 50% of patients are above 65 years of age.  
The project developed an evaluation method related to hospital care of CHD, allowing comparison of 
performance among European hospitals. The participation of the European Federation of Hospitals 
(HOPE) ensured that a large number of hospitals across Europe took part in the study - the patient 
sample came from 200 hospitals across seven European countries. 
3.1.3 Concrete outcomes 
The project developed a set of predictive mathematical functions to assess the quality of management 
of myocardial infarction (MI) or unstable angina (UA) patients through three different medical 
procedures: coronary angiography, thrombolysis and percutaneous intervention. 
Hospital admission and discharge data were analysed so as to study the differences in patient cases and 
the specialization levels of participating institutions.  
The project delivered an interactive website where hospital managers can easily compare the 
performance quality of the institutions. 
The project demonstrated that there is a great interest for an objective and reliable assessment method, 
when hospital managers can use it on a voluntary basis. 
For more information: http://ec.europa.eu/eahc/projects/database.html?prjno=20081312 
3.2 ENERCA 3 - European Reference network of expert centres in rare anaemias 
3.2.1 Background information 
The project was funded under the 2008 work plan of the first Public Health Programme 2003-2008, 
with funding from the EU totalling EUR 1.193.799, 97. It started in June 2009 and ended in November 
2012. 
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 3.2.2 Brief description 
The main objective of ENERCA 3 was to establish a European Reference Network of Expert Centres 
in Rare Anaemias. The first task was to identify appropriate Expert Centres and to foster their 
cooperation by providing a platform for this purpose.   A specific network website (www.enerca.org) 
which had been developed under previous ENERCA 1 and 2 projects was used to provide support for 
information and use of communication technologies such as telemedicine. The Expert Centres were 
asked to include in their activities effective sharing of expertise and knowledge in order to facilitate 
the treatment of patients to improve the cooperation between relevant experts and the exchange of 
professionals nationally and at the EU level.  
3.2.3 Concrete outcomes 
The main outcome of the project was the establishment of a European Reference Network of Expert 
Centres in Rare Anaemias. This work involved the identification of Expert Centres, an analysis of the 
legal and ethical issues related to patient care at the national, EU and international levels and 
identification of the key players across the Member States.  
A set of laboratory procedures and guidelines for the laboratory diagnostics of sickle cell disease, 
thalassemia, and very rare anaemias were developed and the partners promoted quality assurance and 
accreditation of laboratory systems throughout Europe by identifying available accredited External 
Quality Assurance Services (EQAS) in rare anaemias and performing educational EQAS exercises. 
The project also contributed to international efforts for the collection of data on rare anaemias with the 
aim of improving the diagnosis, treatment and more generally, the management and epidemiological 
surveillance of this set of rare diseases across Europe. 
Finally, six courses (three European and three national) on rare anaemias for Continuous Medical 
Education and Training were organised and an educational video on hemoglobinopathies was 
produced. 
For more information: http://ec.europa.eu/eahc/projects/database.html?prjno=20081210 
 
3.3 NBS Screening project: Evaluation of population newborn screening practices 
for rare disorders in Member States of the European Union 
3.3.1 Background information 
This service contract was funded under the 2009 work plan of the second Health Programme 2008-
2013, with funding from the EU totalling EUR 399.755. It started in January 2010 and ended in 
January 2012. 
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 3.3.2 Brief description 
This study aimed to review the state of the art of new born screening practices for rare disorders across 
the EU and to develop a set of recommendations and tools addressing the consequences of differing 
practices among Member States. 
Since the first tests for new born screening (NBS) were developed in the late 1960s and early 1970s, 
technological innovation has led to new methods of testing and, in consequence, to significant 
variations in the way EU Member States are defining and applying screening programmes. 
3.3.3 Concrete outcomes 
An EU-wide network of experts was set up, primarily to review and analyse the collected information. 
The experts reviewed the key aspects of current NBS programmes for rare disorders among the EU 27. 
They produced an extensive report on information related to the number of centres, estimation of the 
number of infants screened and the number of disorders included in the screening programmes.  
Subsequently, a consensus opinion was developed with a set of concrete recommendations on best 
practices. This opinion has also been endorsed by the EU Committee of experts on Rare Diseases in 
2012. 
Finally, the project also produced a decision-making matrix that could be used by Member States 
when reviewing their national screening programmes. 
More information: http://www.euro.who.int/en/what-we-do/health-topics/communicable-
diseases/hivaids/activities/ec-who-project-scaling-up-access-to-high-quality-harm-reduction/ec-who-
grant-agreement-on-harm-reduction 
 
3.4 PITOC: Public Information Tobacco Control 
3.4.1 Background information 
The project was funded under the 2008 work plan of the second Health Programme 2008-2013, with 
funding from the EU totalling EUR 188.952. It started in January 2010 and ended in January 2012.  
3.4.2 Brief description 
The aim of the project was to contribute to the reduction of smoking-related morbidity and mortality 
by supporting the implementation of EU tobacco products legislation. Directive 2001/37/EC stated 
that part of the data on tobacco ingredients, submitted by manufacturers, must be also disseminated to 
the consumers. 
The project aimed to produce information documents (factsheets) on 14 tobacco ingredients which 
pose the highest health hazards regarding their nature and the amount in which they are generally 
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 added: sugars + caramel, glycerol, propylene glycol, sorbitol, cacao, aldehydes, ammonia, menthol, 
liquorice, prune, carob bean, guar gum, vanillin (or lactic acid) and cellulose fibre. 
3.4.3 Concrete outcomes 
As a main result, 16 European countries collaboratively launched websites that inform the general 
public on the general and tobacco industry use of tobacco additives as well as their harmful health 
effects. The fact sheets on tobacco ingredients and their dangers to health have been disseminated via 
the websites. In addition, health professionals were provided fact sheets for use in public health 
practices. Finally, guidance was also provided to policy makers regarding regulation of the contents of 
tobacco products.  
For more information: http://ec.europa.eu/eahc/projects/database.html?prjno=20081229 
 
3.5 Project Take Care: Strategies towards responsible alcohol consumption for 
adolescents in Europe 
3.5.1 Background information 
The project was funded under the 2009 work plan of the second Health Programme 2008-2013, with 
total funding from the EU totalling EUR 900,000. It started in March 2010 and ended in November 
2012. 
3.5.2 Brief description 
The overall objective of the project was to reduce alcohol consumption and the related harm to 
adolescents and young adults in Europe. To do so, it developed and implemented concrete strategies 
and interventions which encouraged the responsible handling of alcohol by adolescents and teens, 
mainly focusing on youths between 12 and 21 years old.  
Specifically, the project aimed to appraise and consolidate relevant best practices in the partner 
countries, to develop and implement a multi-level approach and draft manuals with and for adolescents 
and young adults, parents and other key persons and to put in practice a training module for retailers. 
The project focused on a multilevel approach, i.e. that interventions are more effective and reinforce 
each other if they take place in a defined social environment (urban quarter, community) and are 
directed at different target groups simultaneously. 
3.5.3 Concrete outcomes 
Adolescents participated in a four-day “ro.pe-Training©”. Parents and so-called key-persons 
(important figures in the adolescents' lives) received support to develop a clear and reflective attitude 
towards the use of alcohol, through dedicated trainings. Employees in retail in the social environment 
10 
 received information materials and coaching on everyday sales situations regarding alcohol and the 
compliance with the law on the sale of alcohol through “First-Rate Retailer Tools”. 
The project had a direct and measurable impact on all specific target groups. The consumption of 
alcohol by adolescents having risky patterns of drinking alcohol was reduced in amounts and/or 
frequency by almost 50% in the reference period. The project also improved the knowledge and 
competence of parents, key-persons and retailers to deal confidently with adolescents who consume 
alcohol. Finally, the project revealed an alarmingly low level of knowledge regarding the legislation 
on the sales of alcohol to minors.  
The project delivered a comprehensive manual covering all aspects of the action.  
More information: http://ec.europa.eu/eahc/projects/database.html?prjno=20091220 
3.6 PHGEN II European Best Practice Guidelines for QA, Provision and Use of 
Genome-based Information and Technologies 
3.6.1 Background information 
The project was funded under the 2008 work plan of the second Health Programme 2008-2013, with 
total co-funding from the EU of EUR 1.301.693. It started in June 2009 and ended in November 2012. 
3.6.2 Brief description 
The objective of the project was to produce an EU-wide set of best practice guidelines on the 
application of genome-based knowledge and technologies to support the development of personalized 
medicine across the European Union.  It followed up on the PHGEN I (Public Health Genomics 
European Network).  
3.6.3 Concrete outcomes 
The most important results of the project are as follows: 
- Development of the European Best Practice Guidelines for Quality Assurance, Provision and Use of 
Genome-based Information and Technologies (summarized and endorsed as the “Declaration of 
Rome”) which was published in the journal 'Drug Metabolism and Drug Interactions".  
- Compilation of the existing evidence in the field of Genome-based Information and Technologies. 
For more information: http://ec.europa.eu/eahc/projects/database.html?prjno=20081302 
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 3.7 Correlation II: European Network Social Inclusion and Health 
3.7.1 Background information 
The project was funded under the 2008 work plan of the first Health Programme 2003-2008, with the 
co-funding from the EU totalling EUR 894.145,28. It started in April 2009 and ended in March 2012. 
3.7.2 Brief description 
The aim of the project was to improve prevention, care and treatment services on blood-borne 
infectious diseases, and in particular, on Hepatitis C and HIV/AIDS among vulnerable and high risk 
populations such as drug users and young people at risk. Concretely, the Correlation network focused 
on increasing access to services and the quality of health promotion interventions, strengthening 
capacities among health service providers and influencing health policies.  
3.7.3 Concrete outcomes  
For the e-health strategies in the field of prevention, a Social Intervention Tool and a related training 
module was developed. It can be used by service providers for e-Health, e-counselling and e-therapy 
by using online chatting (http://digitalhealth.eu/). 
As regards peer education, a peer support strategy and peer-based health promotion and prevention 
strategies, the existing literature and manuals were reviewed and a peer support website was set up 
including curricula and description of various good practices for peer support.  
Concerning Hepatitis C, a booklet was produced on good practices related to intervention strategies 
“Hepatitis C: Transmission and Injecting Drug use: Harm Reduction Responses”. Furthermore, a 
training tool was developed and field tested with 27 representatives from 13 countries (RO, SK, SE, 
NL, ES, FR and ENP countries including Ukraine, Russia, Moldova, Serbia, and Albania). The 
manual was translated into Russian, Swedish and Spanish.  
Finally, concerning HIV/AIDS, a set of evidence based policy recommendations was developed on 
prevention related to special risk groups. The recommendations were presented at the European 
Parliament seminar on 29-30 June 2011 and at the final conference in December 2011 in Ljubljana. 
For more information: http://ec.europa.eu/eahc/projects/database.html?prjno=20081201 
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 4  HEALTH INFORMATION 
4.1 SCPE-NET - Surveillance of cerebral palsy in Europe: best practice in 
monitoring, understanding inequality and dissemination of knowledge 
4.1.1 Background information 
The project was funded under the 2008 work plan of the second Health Programme 2008-2013, with 
co-funding from the EU totalling EUR 600,000. It started in October 2009 and ended in December 
2012. 
4.1.2 Brief description 
This project aimed at improving the health and wellbeing of children with Cerebral Palsy (CP) in all 
European countries. The specific objectives were to disseminate information and best practice aimed 
at children with CP to parents and professionals and to document variations in health care provision, 
access and outcomes in children with cerebral palsy. In addition, the project aimed at improving the 
collection, recording, description and use of clinical and epidemiological data on CP. Finally, the 
project aimed at making recommendations for monitoring CP and intellectual impairment at regional 
or national level, and also possibly translating this new knowledge and experience on CP to other 
childhood impairments and chronic conditions. 
4.1.3 Concrete outcomes 
The main outcomes of the project were a set of recommendations on best practice in clinical 
information of children and young people with CP, a newly developed classification and scale and 
evidence on variations in a series of clinical interventions and outcomes across Europe. The project 
also included an analysis by socioeconomic status using the limited available data. A proposal for 
obtaining quality and comparable socioeconomic data in the EU CP registers is now available.  
The SCPE-NET project increased the SCPE common database by more than 3000 cases. Innovative 
data analysis methods were incorporated and new epidemiologic data were published.  
The publicly open and multilingual website developed by SCPE-NET is a platform for disseminating 
epidemiological information on CP and innovative medical education materials such as the SCPE 
Reference and Training Manual.  
For more information:  http://ec.europa.eu/eahc/projects/database.html?prjno=20081307 
 
4.2 EURO-GBD-SE: The potential for reduction of health inequalities in Europe  
4.2.1 Background information 
The project was funded under the 2008 work plan of the second Health Programme 2008-2013, with 
total co-funding from the EU of EUR 749.950,38. It started in July 2009 and ended in June 2012. 
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 4.2.2 Brief description 
EURO-GBD-SE project had three main objectives; 1.) to provide updated estimates of the magnitude 
of socioeconomic inequalities in health in Europe; 2.) to assess the contribution of risk factors to these 
health inequalities and; 3.) to analyse the extent to which health inequalities in Europe can be reduced 
by policies and interventions focusing on socioeconomic determinants and specific risk factors. 
4.2.3 Concrete outcomes 
The project demonstrated that inequalities in mortality and morbidity in Europe have persisted into the 
21st century, and manifest themselves in patterns that are broadly similar to those seen in the 1990s. 
This implies that they continue to be one of the main challenges for public health policy. The project 
also showed that the explanation of inequalities in mortality, in terms of the quantitative contribution 
of specific risk factors, differs between European countries. This implies that different countries have 
different entry-points for policies to tackle health inequalities.  
 
Furthermore, the project has shown that many countries can reduce their relative inequalities in 
mortality by up to 10, 20 or even 30% if they would succeed in reducing inequalities in one or more 
risk factors to the level currently seen in the European country with the smallest inequalities in 
exposure.  
For more information: http://ec.europa.eu/eahc/projects/database.html?prjno=20081309 
 
4.3 OECD: Cooperation on key areas of work of the Health Committee of the 
Organisation for Economic Co-operation and Development (OECD) 
4.3.1 Background information 
This Direct Grant Agreement project was funded under the 2009 work plan of the second Health 
Programme 2008-2013, with the funding from the EU totalling EUR 600,000. It started in August 
2010 and ended in December 2012. 
4.3.2 Brief description 
The aim of this project was to improve analysis of different health systems to enhance the capacity of 
the European Commission and the OECD to compare hospital efficiency and performance across 
countries. The project aimed at developing modelling on the effectiveness, efficiency and 
distributional impact of health interventions and comparing the performance of the hospital sector.  
Hospital sector comparisons were seen as a key component in achieving a better estimate of the 
impacts of health interventions. Such interventions were essential to develop tools to support health 
policies and integrated approaches in the areas of prevention and treatment of chronic diseases. 
14 
 4.3.3 Concrete outcomes 
First, work consisted of testing and validating a modelling template (so-called CDP 2.0 template) 
which is the first computer simulation to dynamically model the complex relationships deriving from 
interactions between socio-economic factors, epidemiological trends, treatment pathways and the 
organisation and financing of health care. This was done for all major non-communicable diseases to 
compare the effectiveness of policy interventions from prevention to treatment and long-term care.  
Second, work focused on continued data collection on surgical interventions and identifying the 
reasons behind large variations in surgical activity rates across the EU. It was found out that some of 
these variations reflect data comparability limitations. Nevertheless, a significant part of the variations 
reflect real and important differences in surgical activity rates. 
Third, results show that the volume and type of surgical procedures performed in hospitals have 
evolved over time, some types of surgical interventions growing rapidly (e.g., cataract surgery, hip and 
knee replacement) and other interventions declining as they are replaced by improved techniques (e.g., 
coronary bypass surgery, appendectomy).  
Finally, an improved capacity for hospital efficiency and performance comparisons was considered 
useful as regards a possible extension of the joint OECD/Eurostat/WHO-Europe efforts on health care 
statistics.  
For more information: 
http://ec.europa.eu/health/projects/docs/2010_health_healthcare_policy_fr_en.pdf  
and 
http://ec.europa.eu/health/projects/docs/2010_hospital_procedures_fr_en.pdf 
 
2nd Part : Budget Implementation Report 2012 
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1 BUDGET 
The budget for the second Health Programme for the period 2008-2013 is EUR 321.5 million. The 
budget set out in the work plan for 20121 was EUR 49 700 000. This was broken down as follows: 
Operational expenditure: EUR 48 300 000 corresponding to budget line 17 03 06 — EU 
action in the field of health;  
Administrative expenditure: EUR 1 400 000 corresponding to budget line 17 01 04 02 — 
Expenditure on administrative management. 
With the inclusion of EFTA/EEA and Croatia credits and recovery credits from previous budgetary 
years, the total operational budget amounted to EUR 51 590 623 and the total administrative budget to 
EUR 1 436 400. 
The former Executive Agency for Health and Consumers (EAHC) which in January 2014 was 
renamed as the Consumers, Health and Food Executive Agency (CHAFEA), has been providing the 
Commission with technical, scientific and administrative assistance in implementing the Health 
Programme since 20052. The CHAFEA organises annual calls for proposals, coordinates the 
evaluation of submissions, and negotiates, signs and manages related grant agreements. The CHAFEA 
is also responsible for many procurement procedures. In 2012, the CHAFEA managed EUR 34 434 
936,01 and the Commission managed the remaining EUR 16 920 727,63 covering procurement and 
some other actions. 
1  OJ C 358, 8.12.2011 p.8 
2  Decision 2004/858/EC of 15 December 2004 (OJ L 369, 16.12.2005, p. 73) amended by Decision 
2008/544/EC of 20 June 2008 (OJ L 173, 3.7.2008, p. 27). 
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 2 PRIORITIES FOR 2012 AND FINANCING MECHANISMS 
The priorities for 2012 were set out in Commission Implementing Decision 2011/C 358/06 of 1 
December 2011 adopting the 2012 work plan and related criteria3.  
 The following financing mechanisms were used to implement the work plan for 2012: 
Project grants: these are awarded to projects involving several partners, usually public health 
bodies and non-governmental organisations (NGOs). The maximum EU contribution 
is 60 % of eligible costs. However, the EU contribution may go up to 80% if a 
proposal meets the criteria for exceptional utility. 
Operating grants: these are awarded to non-profit organisations or specialised networks active 
in areas corresponding to the three objectives of the programme. Such bodies must 
be non-governmental, non-profit, and independent of industry or other conflicting 
interests and have as their primary objectives one or more goals of the programme. 
The maximum EU contribution is 60 % of their annual operating costs. However, the 
EU contribution may go up to 80% if a proposal meets the criteria for exceptional 
utility. 
Grants for joint actions: these are awarded to Member States’ authorities or bodies designated 
by them. The maximum EU contribution is 50 %. However, the EU contribution may 
go up to 70% if a proposal meets the criteria for exceptional utility. Exceptional 
utility co-financing of 70% was envisaged for the joint action "Facilitating 
collaboration on organ donation between national authorities in the EU" because of 
its contribution to the effective implementation of EU legislation in this field. 
Conference grants: these go towards conferences on public health issues, organised by public 
bodies or non-profit organisations and the EU Council Presidencies. The maximum 
EU contribution is 50 % of eligible costs. 
Direct grant agreements with international organisations are awarded to international 
organisations active in the area of public health. The maximum EU contribution is 
60 %. 
Procurement (service contracts): these are used to purchase services, such as evaluations, 
studies, data procurement and IT applications. The Health Programme fully covers 
the cost of procurement actions. 
Competitive selection and award procedures are used to select actions for funding, with the 
exception of direct grant agreements and conferences organised by Council Presidencies, 
which represent de facto or de jure monopolies. 
Administrative credits cover expenditure such as studies, meetings of experts, information and 
publication costs, and technical and administrative assistance for IT systems. 
3  OJ C 358, 8.12.2011 p.8 
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 3 IMPLEMENTATION OF THE OPERATIONAL BUDGET BY FINANCING MECHANISM 
 
Number of 
grants / 
contracts 
signed 
Type of financing mechanism Implementation € Share of 
mechanism in 
total executed 
budget  
65  Calls for proposals: 29 720 558,01 
 
57.88% 
19 Project grants 15 734 934,53 
 
30.64% 
9 Conference grants 
757 782,33 
 1.48% 
19 Operating grants 4 327 879.,85 
 
8.43% 
5 Grants for joint actions 8 899 961,30 17.33% 
3 Direct grant agreements 2 633  000,00 5.13%% 
11 Procurement (service contracts) 
14 275 784,38 
 27.80% 
 Managed by CHAFEA 2 081 378,00 4.05% 
 Managed by DG SANCO 12 194 406,38 23.75% 
 Other actions  
                             Managed by DG SANCO 
4 726 321,24 9.20% 
  Executed budget in 2012  51 355 663,63 
  
100% 
  Total available budget 51 590 623,00  
 Credits not used (pre-accession credits 
not yet used, differences between 
amounts in the award decision and 
amounts actually contracted) 
234 959,37  
 Level of budget execution 99,5%  
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For comparison, in 2011, project grants amounted to 6.98 Mio €, and grants for joint actions 16.55 
Mio €. The budgets amounted to other financing mechanisms were similar to 2012: conference grants 
0.7 Mio €, operating grants 4.01 Mio €, direct grants 3.2 Mio €, and procurement 15.14 Mio €.  
3.1 Calls for proposals 
Four calls for proposals — for projects, conferences, operating grants and joint actions —were 
launched on 8 December 2011 on the Public Health Europa website4 and the CHAFEA website5. The 
calls were also published in the Official Journal of the European Union6. The calls closed on 9 March 
2012. The majority of applications were received from main partners in EU-15 Member States: 85% 
of project applications, 84% of conference grant applications, 97% of operating grant applications, and 
100% of joint action applications. 
The CHAFEA organised a joint action workshop in December 2011 and a joint action quality 
assurance workshop in February 2012. Information days were organized in Brussels (for the European 
Innovation partnership on Active and Healthy Ageing), Italy and Greece. Guidelines for applicants 
were made available on the CHAFEA website. The CHAFEA helpdesk also provided assistance and 
practical help. 
Altogether, 180 applications were submitted for an amount totalling EUR 87 220 234 with ten having 
been excluded already in the screening phase. Out of the 170 remaining applications, 47 (27,6%) were 
recommended for funding. Applications were evaluated in accordance with the rules and criteria set 
out in Commission Decision 2011/C 69/01 and the calls for proposals7. Applications were evaluated 
by 38 external experts, coming from 18 countries, drawn from a list that was established following a 
call for expressions of interest: ‘Experts for the second programme of Community action in the field of 
health in various evaluation activities’8. 
The evaluation process took place in two stages. 
In the first stage, three external evaluators reviewed each proposal. A consolidated evaluation report 
for each proposal was drawn up at a meeting organised by the CHAFEA. 
In the second stage, an evaluation committee checked that the evaluators had adhered to the relevant 
rules and criteria. It then drew up final lists of proposals recommended for funding together with 
reserve lists. The evaluation committee comprised representatives from the Directorate-General for 
Health and Consumers, the Directorate-General for Research and Innovation and the CHAFEA. 
The committee of the second programme of Community action in the field of health (2008-13) issued 
a favourable opinion on the actions proposed for funding at its meeting on 29 June 2012. The related 
awarding Commission Decision was adopted on 5 July 20129. 
4  http://ec.europa.eu/health/programme/policy/index_en.html  
5  http://ec.europa.eu/eahc/health/health.html  
6 OJ C/358, 8.12.2011 
http://ec.europa.eu/eahc/documents/health/calls/2012/WP_2012_en_for_projects.pdf  
7  OJ C 69/01, 3.3.2011 
8 OJ S 65, 2.4. 2011 and http://ec.europa.eu/eahc/phea_ami/ 
9 http://ec.europa.eu/health/programme/docs/award_decision2012.pdf  
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 3.1.1 Project grants 
In all, 88 proposals were submitted in response to the call for proposals for projects. 16 proposals were 
recommended for funding and 5 were placed on a reserve list. In the end, 19 projects were funded for a 
total of EUR 15 734 934, 53. Their distribution among the programme strands was as follows: 
1. Health security:  EUR 1 046 166 (2 projects) 
2. Health promotion:  EUR 14 688 768.53 (17 projects) 
Annex 1 contains a table of the projects funded. The CHAFEA database10 provides abstracts of these. 
96% of successful projects were presented by main partners in EU-15. The participation rate of EU-12 
country associate partners however is at 23%.  
3.1.2 Conference grants 
A total of 41 proposals were submitted in response to the call for proposals for conferences. Seven 
proposals were recommended for funding and two were put on the reserve list. In the end, seven out of 
the 41 conferences (17%)  under the call for proposals and two conferences organised by the 
Presidencies of the European Council were funded for a total budget of EUR 757 782,33. Their 
distribution among the programme strands was as follows: 
3. Health promotion: EUR 233 685,33 (2 conferences + presidential conference CY) 
4. Health information: EUR 524  097,00 (5 conferences + presidential conference IE) 
The conferences addressed: cancer, equity in health, health promotion, public health in general, 
Alzheimer’s, rare diseases and orphan products, organ transplantation and workplace health. The 
Cypriot Presidency conference focused on healthy ageing, and the Irish Presidency conference on 
eHealth. 
Annex 2 and Annex 3 contain tables of the conferences funded. The CHAFEA database provides 
abstracts of these. 
3.1.3 Operating grants 
A total of 40 proposals were submitted in response to the call for proposals for operating grants. Of 
these, 19 were proposed for funding and two (2) were placed on a reserve list. In the end, 19 proposals 
─ 8 new proposals and 11 renewal proposals ─ were funded out of the 40 submitted (47.5%) for a total 
of EUR 4 327 879,85. 
New operating grants were awarded to: the Academic Medical Centre Amsterdam (ESPN/ERA-
EDTA: network on rare kidney diseases); the Foundation De Regenboog Groep (coordination of the 
Correlation network – social inclusion and health11); the Fundación Vasca de Innovación e 
Investigación Sanitarias (network of neonatal intensive care units); the International Association for 
Ambulatory Surgery (I.A.A.S.); the International Union for Health Promotion and Education 
(I.U.H.P.E.); the Statens Serum institute (EURO-MoMo network: real-time mortality monitoring 
across Europe) and the University of Newcastle upon Tyne (network on rare neuromuscular diseases). 
CBO B.V. was awarded a grant for continuation of the Schools for Health in Europe network – SHE 
network, after the closure of the Netherlands Institute for Health Promotion (NIGZ).  
10 http://ec.europa.eu/eahc/projects/database.html. 
11  This network was created under the project Correlation II: European Network Social Inclusion and 
Health funded in 2008 with funds from the Health Programme for a three years period (see above p. 14) 
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 Renewals were awarded to: Alzheimer Europe; EUROPA DONNA; the European Alcohol Policy 
Alliance (EURO-Care); the European Multiple Sclerosis Platform (EMSP); the European Patients’ 
Forum (EPF); the European Network for Smoking and Tobacco Prevention (ENSP); the European 
Organisation for Rare Diseases (EURORDIS); the European Public Health Alliance (EPHA); 
PREVENT (for the European network on workplace health promotion); Stichting Aids Fonds Soa 
Aids Nederland; and Stichting Health Action International (HAI).  
Annex 4 contains a table of the operating grants funded. The CHAFEA database provides abstracts of 
these. 
3.1.4 Joint actions 
Five proposals for joint actions were submitted and funded for a total of EUR 8 899 961.30. 
They were distributed among the programme strands as follows: 
5. Health security:  EUR 4  443 024,30 (3 joint actions) 
6. Health promotion:  EUR 4  456  937,00 (2 joint actions) 
These joint actions, involving a large number of Member States and third countries taking part in the 
programme, focused on: organ donation; quality in HIV/AIDS prevention; maritime transport and 
health threats; mental health; and health workforce planning. 
Annex 5 contains a table of the joint actions funded. The CHAFEA database provides abstracts of 
these.  
3.2 Direct grant agreements with international organisations 
In all, 4 direct grant agreements were signed for a total of EUR 2 633 000 as follows: 
7. Council of Europe concerning cooperation on substances of human origin; 
8. International Organization for Migration (I.O.M.) concerning health provision  for migrants, the 
Roma and other vulnerable groups; 
9. Organisation for Economic Cooperation and Development (OECD) concerning cooperation on 
health information; 
10. Commission membership at the European Observatory on Health Policies and Health Systems 
Annex 6 contains a table of the direct grant agreements that were funded. 
3.3 Procurements (service contracts) 
A number of service contracts have been signed by DG SANCO, 12 of them under Health Security, 7 
under Health Promotion and 26 under Health Information, and a series of specific requests for IT 
services on the basis of existing framework contracts. The overall budget managed by DG SANCO 
amounts €12 194 406, 38 million. CHAFEA managed 13 service contracts ( 6 under Health Security, 3 
under Health Promotion and 4 under Health Information) for a total of EUR 2 081 378,00. The 
amounts per strand and authorising organisation are as follows:  
21 
  
Programme objective 
Tenders / 
contracts 
SANCO 
Tenders / 
contracts 
CHAFEA 
Total tenders / 
contracts 
Health Security 205 183,19 1 133 161 1 338 344,19 
Health Promotion 9 366 607,80 299 453 9 666 060,80 
Health Information  1 756 239,51 648 764 2 405 003,51 
Transversal (IT services) 866 375,88 0 866 375,88 
Total 12 194 406.38 2 081 378 14 275 784,38 
 
These contracts covered needs as specified in the work plan for 2012: evaluation and monitoring of 
actions and policies, studies, provision of advice, data and information on health, scientific and 
technical assistance, communication and awareness-raising activities and IT applications in support of 
policies. 
Annexes 7 and 8 provide more detail about the service contracts signed.  
 
3.4 Other actions 
A sum of EUR 4 726 321, 24 was earmarked for other actions in 2012. This covered special 
indemnities to experts for their participation in and work for the EU Scientific Committees in line with 
Commission Decision 2008/721/EC12 for a total of EUR 270 00 sub-delegations to other Commission  
Directorates for the organisation of conferences/events and IT  services. This also covered an 
administrative agreement with the Joint Research Centre (JRC) for the harmonisation and 
development of cancer information in the EU for a total amount of EUR 4 000 000. The administrative 
agreement foreseen with JRC on scientific policy support on tobacco for a total of EUR 100 000, 00 
was not implemented. 
4 IMPLEMENTATION OF THE OPERATIONAL BUDGET BY PROGRAMME OBJECTIVES 
4.1 Global budget consumption in 2012 
The graph below illustrates how the budget was used in 2012 according to the three programme 
strands.   A total of EUR 7 598 433, 49 was spent on health security, EUR 36 577 525,51 on health 
promotion and EUR 6 313 328,75 on health information. Finally, EUR 866 375,88 was invested in IT 
services necessary to support the three strands. 
12 OJ L 241, 10.9.2008, p. 21. 
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4.2 Health security: EUR 7 598 433, 49 – 15 % of the operational budget in 2012 
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4.3 Health promotion: EUR 36 577 525, 51 – 71 % of the operational budget in 2012 
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4.4 Health Information EUR 6 313 328, 75 – 12 % of the operational budget in 2012 
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ANNEX 1 –Project grants (signed and committed) 
 
 
HEALTH SECURITY 
Number Acronym Title  Amount 
3.1.2 ECHEMNET  European Chemical Emergency Network Protect citizens 
against health 
threats 
    447 600,00 
3.1.2 AIRSAN  Coordinated action in the aviation sector to control public health threats Protect citizens 
against health 
threats 
    598 566,00 
 
Total  
 
1 046 166,00 
 
HEALTH PROMOTION 
3.2.4 NPDR (PRO)/UHB/AD1 An EU rare diseases registry for Niemann-Pick Disease type A, B and C. Prevention of 
major and rare 
diseases 
1 199 597,73 
3.2.4 E-HOD (PRO) / VUMC European network and registry for homocysinurias and methylation defects Prevention of 
major and rare 
diseases 
   690 793,00 
3.2.1 MANAGE-CARE / TUD Active Ageing with Type 2 Diabetes as Model for the Development and Implementation of Innovative Chronic Care 
Management in Europe 
Increasing 
healthy life years 
and promoting 
healthy ageing 
   692 441,40 
3.2.3 HEPCOM (PRO) / CBO Promoting healthy eating and physical activity in local communities Addressing 
health 
determinants 
1 000 000,00 
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 3.2.1 ICARE4EU 
(PRO)/NIVEL 
Innovating care for people with multiple chronic conditions in Europe Increasing 
healthy life years 
and promoting 
healthy ageing 
1 214 321,03 
3.2.4 EUROCRINE (PRO) European Surgical Registry for Rare Endocrine Tumours Prevention of 
major and rare 
diseases 
   700 000,00 
3.2.4 EUROTRACS EUROpean Treatment & Reduction of Acute Coronary Syndromes cost analysis Prevention of 
major and rare 
diseases 
1 198 693,32 
3.2.3 LET IT HAPYN! Empowering the Youth Sector with a better overview of evidence-based Alcohol intervention programmes Addressing 
health 
determinants 
   236 284,09 
3.2.1 ACT (PRO) - PMSB Advancing Care Coordination & TeleHealth Deployment Programme Increasing 
healthy life years 
and promoting 
healthy ageing 
1 596 383,63 
3.2.1 E-CAPACIT8 PROJ Strengthening occupational health professionals' capacities to improve the health of the ageing workforces. Increasing 
healthy life years 
and promoting 
healthy ageing 
   513 707,30 
3.2.4 BENCH-CAN / OECI Benchmarking comprehensive cancer care that provides interdisciplinary treatment for patients, and yield examples 
of best practice in comprehensive cancer care 
Prevention of 
major and rare 
diseases 
473 276,98 
3.2.4 INNERMED-I-
NETWORK 
Inherited NeuRoMetabolic Diseases INFORMATION NETWORK Prevention of 
major and rare 
diseases 
   1 000 000,00 
3.2.4 ECONDA Economics of Chronic Diseases Prevention of 
major and rare 
diseases 
   791 466,37 
3.2.4 EUROMAC European registry of patients with McArdle disease and very rare muscle glycogenolytic disorders (MGD) with 
exercise intolerance as the major symptom (PR-MDMGD) 
Prevention of 
major and rare 
diseases 
   911 578,00 
3.2.4. E-ENERCA / IDIBAPS NEW e-HEALTH SERVICES FOR THE EUROPEAN REFERENCE NETWORK ON RARE ANAEMIAS Prevention of 
major and rare 
1 163 274,82 
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 diseases 
3.2.3. OPEN Obesity Prevention through European Network Addressing 
health 
determinants 
1 053 428,86 
3.2.3. EYTO / NCB European Youth Tackling Obesity Addressing 
health 
determinants 
   253 522,00 
 
Total  
 
 
14 688 768,53 
 
TOTAL PROJECTS 
  
15 734 934,53 
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 ANNEX 2 — Presidency Conference (signed and committed) 
HEALTH PROMOTION 
Number Acronym Title Action Amount 
1 PRESIDENCY 
CONFERENCE CYPRUS - 
HEALTHY AGEING / 
(CONF) / MOH 
Healthy Ageing Across the Lifecycle Increasing 
healthy life 
years and 
promoting 
healthy 
ageing 
58 685,33 
 
Total  58 685,33 
HEALTH INFORMATION 
1 IRISH PRESIDENCY - 
HIGH LEVEL E-HEALTH 
CONFERENCE 2013 
HIGH LEVEL E-HEALTH MINISTERIAL CONFERENCE 2013  100 000 
Total  100 000 
TOTAL PRESIDENCY CONFERENCE  158 685,33 
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 ANNEX 3 — Conference grants (signed and committed) 
HEALTH PROMOTION 
Number Acronym Title Amount 
1 GCHP 8th Global Conference on Health Promotion 75 000,00 
2 HPS EQUITY IN HEALTH THROUGH EDUCATION: THE FOURTH EUROPEAN CONFERENCE ON HEALTH 
PROMOTING SCHOOLS 
100 000,00 
Total  175 000,00 
HEALTH INFORMATION 
1 CCPC CONFERENCE The Second European Colorectal Cancer Patient Conference:  The Power of Patients Voice: The Challenges, Collaboration and 
Change 
70 922,00 
2 ELPAT 2013 (CONF) Organ Transplantation: Ethical, Legal and Psychosocial Aspects. Outreach from the European Platform 100 000,00 
3 PH WORK CONFERENCE Workplace health practices for employees with chronic illness. 73 175,00 
4 23RD ALZHEIMER 
EUROPE CONFERENCE 
23rd AE Conference: Living well in a dementia friendly society 80 000,00 
5 BRUSSELS 2013 Sixth European Public Health Conference 100 000,00 
Total  424 097,00 
TOTAL CONFERENCES 599 097,00 
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 ANNEX 4 –Operating grants (signed and committed) 
HEALTH SECURITY 
Number Acronym Title Amount 
1 SSI_FY 2013 (OG) / AD1 EURO-MoMo network: real-time mortality monitoring across 
Europe 
130 219,00 
2 ED_FY 2013 (OG) AD1 EUROPA DONNA 270 680,00 
Total 400 899,00 
HEALTH PROMOTION 
1 SANL FY2013 - OG / AD 1 Stichting Aids Fonds Soa Aids Nederland 250 000,00 
2 EPHA_FY 2013 (OG) European Public Health Alliance 549 232,00 
3 IUHPE2013 - OG / AD1 International Union for Health Promotion and Education 97 463,00 
4 AE2013 - OG Alzheimer Europe 190 000,00 
5 PREVENT_FY 2013 (OG) European network on workplace health promotion 93 898,00 
6 ENSP FY2013 - OG European Network for Smoking and Tobacco Prevention 201 385,85 
7 EUROCARE_FY2013 - OG - AD 1 European Alcohol Policy Alliance 99 000,00 
8 HAI_FY 2013 (OG) Stichting Health Action International 218 000,00 
9 ESPNEG_FY2013 - OG Network on rare kidney diseases 150 189,00 
10 CBO_FY 2013 (OG) Schools for Health in Europe network – SHE network 149 906,00 
Total 1 999 073,85 
HEALTH INFORMATION 
1 EURORDIS FY_2013 - OG European Organisation for Rare Diseases 579 999,00 
2 EMSP FY_2013 - OG / AD1 European Multiple Sclerosis Platform 279 858,00 
3 EPF_FY 2013 (OG) European Patients’ Forum 568 488,00 
4 FRG_FY 2013 (OG) Correlation network – social inclusion and health 100 581,00 
5 BIOEF FY2013 - OG Network of neonatal intensive care units 100 000,00 
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 6 IAAS_FY2013 - OG / AD 1 International Association for Ambulatory Surgery   99 300,00 
7 UNEW FY2013 - OG Network on rare neuromuscular diseases 199 681,00 
Total 1 927 907,00 
TOTAL OPERATING GRANTS 4 327 879,85 
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 ANNEX 5 –Joint actions (signed and committed) 
 
 
HEALTH  SECURITY 
Number Acronym Title Action Amount 
3.1.4. FOEDUS Facilitating exchange of organs donated in EU member states Safety and 
quality of 
organs 
1 149 902,30 
3.1.2. QHP / BZGA / 
AD 1 
Improving Quality in HIV Prevention Protect citizens 
against health 
threats 
1 493 180,00 
3.1.2. SHIPSAN 
ACT / UTH  
The impact on maritime transport of health threats due to biological, chemical &radiological agents, 
including communicable diseases 
Protect citizens 
against health 
threats 
1 799 942,00 
Total  4 443 024,30 
HEALTH PROMOTION 
3.2.2. EUHWFORCE  
- FPS 
European Health Workforce Planning and Forecasting Health 
inequalities 
2 964 749,00 
3.2.3. MH-WB  Mental health and well-being Addressing 
health 
determinants 
1 492 188,00 
 
Total 
  
4 456 937,00 
 
TOTAL JOINT ACTIONS 
  
8 899 961,30 
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 ANNEX 6 –Direct grant agreements with international organisations (signed and committed) 
 
HEALTH SECURITY 
Number Acronym Title Amount 
1 COE (CONTRIBUTION AGREEMENT) Dissemination of best practices in tissues and cells donation/transplantation 100 000,00 
Total 100 000,00 
HEALTH PROMOTION 
1 EQUI HEALTH IOM Fostering health provision  for migrants, the Roma, and other vulnerable groups 1 533 000,00 
Total 1 533 000,00 
HEALTH INFORMATION 
1 CDP & PSI / OECD Analysis of the cost-effectiveness of chronic disease prevention activities / Further 
work on Patient Safety Indicators 
500 000,00 
2  European Observatory on Health Policies and 
Health Systems 
Commission membership at the European Observatory on Health Policies and Health 
Systems 
500 000,00 
Total 1 000 000,00 
 
TOTAL DIRECT GRANTS 
 
2 633 000,00 
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ANNEX 7 — List of service contracts — procurement (signed and committed by DG SANCO) 
 
HEALTH SECURITY 
Local SI2.KEY Reference Amount in € 
SI2.630392.1 17.030600- DATA SEARCHING MEDICAL DEVICES CONT DEHP PLASTICIZED PVD - OF 46 BRE 8.818,00 
SI2.619841.1 17.030600- DATA MINING ON BREAST IMPLANTS - OF 43 26.378.19 
SI2.637385.1 17.030600/12/637385 - THE SAFETY OF PIP SILICONE BREAST IMPLANTS -  18.380,00 
SI2.641195.1 17.030600/12/641195 - EDITORIAL SUPPORT ON NANO TI02-DEG 2.309,00 
SI2.641232.1 17.030600/12/641232 - SYNTHETIC BIOLOGY N°2 13.999,00 
SI2.617480.1 17.030600- DATA MINING ELECTROMAGNETIC FIELDS - OF 42 25.245,00 
SI2.628267.1 17.030600- EDITORIAL SUPPORT COMMITTEES' OPINION ON NANO ZINC OXIDE- OF 45 BRE 3.072,00 
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 SI2.630631.1 17.0306- PROV COMMITMENT CHILDHOOD IMMUNISATION CONFERENCE OCT 2012 75.000,00 
SI2.631392.1 17.030600- DATA SEARCHING MERCURY IN DENTAL AMALGAMS - OF 47 BRE 10.110,00 
SI2.633583.1 17.030600- LITERATURE SEARCH ON SYNTHETIC BIOLOGY - OF 48 BRE 12.479,00 
SI2.625251.1 17.030600- DATA MINING ON NICOTINE CONTAINING PRODUCTS - OF 44 9.393,00 
SUB-TOTAL  
for Health Security 205.183,19 
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 HEALTH INFORMATION  
Local SI2.KEY Reference Amount in € 
SI2.590486.2 CONTRAT SPECIFIQUE WEBMASTER PROTAIL C1 - EUROPEAN SERVICE NETWORK-DEG 40.000,00 
SI2.590489.2 CONTRAT SPECIFIQUE SR PROJECT MANAGER PROTAIL C1 - EUROPEAN SERVICE NETWORK-DEG 55.400,00 
SI2.616211.2 17.030600 - CS N°5870 - IRIS - EU PUBLIC HEALTH PORTAL AND WEBSITE - V.CHALLINOR 96.135,60 
SI2.617343.1 17.030600 - TNS - EUROBAROMETER ON TOBACCO IN 27 MS 499.153,00 
SI2.619733.1 17.0306- PROV COMMITMENT HEALTH PROGRAMME CONFERENCE 63.000,00 
SI2.620124.1 17.030600-CS N°6023-IRIS-EU PUBLIC HEALTH PORTAL AND WEBSITE- 3 WEBMASTERS - DEG -  178.975,78 
SI2.625700.1 17.030600 - JOURNALISM PRIZE 2012 40.000,00 
SI2.628272.1 3RD JOURNALIST WORKSHOP ON ORGAN DONATION AND TRANSPLANTATION OCTOBER 2012 - DEG 40.000,00 
SI2.628444.4 17.030600 ET 08.010503/12/628444 - GASTEIN 2012 - DEG -  29.937,40 
SI2.637079.1 17.030600/12/637079  - HEALTH PORTAL AND WEBSITES -  133.160,00 
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 SI2.640217.1 17.030600/12/ 640217 - EU HEALTH FORUM - EPHA - 54.911,60 
SI2.642991.1 17.030600/12/642991 - USE AND IMPACT OF THE EC HEALTH INDICATORS ECHI 93.512,50 
SI2.617458.1 17.00306-LAY OUT WORK E-NEWSLETTER & CD-ROMS - MEDIA CONSULTA 4.958,63 
SI2.624425.1 17.030600/12/ 624425 - CRAWLER FOR THE EU PUBLIC HEALTH PORTAL -COMPL SI2.581361 - MOD FDI 17.769,00 
SI2.625148.2 17.030600- VIDEO ON NUTRITION OVERWEIGHT OBESITY RELATED HEALTH ISSUE - EMAKINA 0,00 
SI2.628296.1 CONTRAT SPECIFIQUE 2 WEBMASTERS PORTAIL C1 - EUROPEAN SERVICE NETWORK - DEG - 76.520,00 
SI2.628444.2 17.030600 ET 08.010503/12/628444 - GASTEIN 2012 - DEG -  132.670,54 
SI2.628992.1 EU HEALTH FORUM - PLANNING ACTIVITES 01/08/2012 - 15/09/2012 - EPHA 6.097,50 
SI2.635403.1 C1-17.030600/12/ 635403 - ADDITIONAL FEATURES SEARCH ENGINE HEALTH PORTAL-HON 4.999,00 
SI2.642991.2 17.030600/12/642991 - USE AND IMPACT OF THE EC HEALTH INDICATORS ECHI 5.137,50 
SI2.643024.1 D3 - EMF CONFERENCE - BRUSSELS - 20/02/2013 44.000,00 
SI2.643050.1 17.030600-CS N°8819-IRIS-EU PUBLIC HEALTH PORTAL AND WEBSITE- 2 WEBMASTERS LUX 83.226,00 
SI2.643060.1 17.030600-CS N°8816-IRIS-EU PUBLIC HEALTH PORTAL AND WEBSITE- 1 WEBMASTER LUX 49.295,40 
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 SI2.628444.3 17.030600 ET 08.010503/12/628444 - GASTEIN 2012 - DEG -  7.380,06 
SUB-TOTAL  
for Health Information 1.756.239,51 
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HEALTH PROMOTION 
Local SI2.KEY Reference Amount in € 
SI2.626153.1 17030600/12/626153 - EVALUATION ON IMPLEMENTATION NUTRITION, OVERWEIGHT, OBESITY 271.850,00 
SI2.632468.1 COMMUNICATION CAMPAIGN ON SMOKING CESSATION - PART 3 - SAATCHI & SAATCHI 8.913.980,00 
SI2.641552.1 C4-17.030600-MONITORING OF EU PLATFORM ON DIET, PHYSICAL ACT & HEALTH 72.750,00 
SI2.632025.1 HEALTH POLICY FORUM - 25 OCT 2012 - BXL - EPHA 14.079,00 
SI2.622424.1 EU HEALTH FORUM - PLANNING ACTIVITES 01/05/2012 - 31/12/2012 23.948,80 
SI2.643156.1 17.030600/12/643156- 2013 MONITORING ACTIVITIES BY EAHF 40.000,00 
SI2.620498.1 17.030600/12/620498 - ASSESS QUALITY OF THE 2012 ACTIVITIES MONITORING BY EAHF 30.000,00 
SUB-TOTAL  
for Health Promotion 9.366.607,80 
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IT SERVICES 
Local SI2.KEY Reference Amount in € 
SI2.619020.1 CS N°006355 - EXTENSION PUBLIC HEALTH CONSULTANT IN LUX - MOD FDI 57.536,00 
SI2.619495.2 ORDER FORM N°1135 - SMARTBEAR  SOAPUIPRO LICENCE 665,00 
SI2.620686.1 CS N°006441 - EXTENSION FOR DOCUMENTUM SPECIALIST - CD 15.000,00 
SI2.622508.1 CS N°006681 - EXTENSION FOR J2EE TEAM 192.034,10 
SI2.622530.1 CS N°006678 - EXTENSION FOR PUBLIC HEALTH TEAM - DEG 79.528,98 
SI2.622753.2 ORDER FORM N°1259 - LICENCES BAMBOO - RNW 1.300,00 
SI2.623247.1 CS N°007070 - IS SENIOR CONSULTANT FOR ORACLE APPLICATIONS 65.858,00 
SI2.623688.2 CS N°006784 - SAP FOR ORACLE - CD 9.000,00 
SI2.625636.1 CS N°000796 - EXTENSION FOR WEB ADMINISTRATOR - DEG 13.504,83 
SI2.625786.3 CS N°006877 - EXTENSION RAPEX, ADNS, HEALTH TEAM LUX & BXL 110.629,52 
SI2.629832.7 CS N°7552 - DOCUMENT, WEB CONTENT AND GEOGRAPHICAL MANAGEMENT PROJECTS - CD 60.000,00 
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 SI2.631306.5 CS N°188 - LOCAL OPERATION SERVICES 12/2012 - 5/2013 - CD 50.000,00 
SI2.634573.3 CS N°008104 - EXTENSION FOR ORACLE SPECIALIST - DEG 5.563,57 
SI2.635473.2 CS N°008182 - PROGRAMMER ASP.NET & C# PROGRAM PROJECTS 16.708,00 
SI2.636060.1 CS N°008177 - ANALYST FOR BO TEAM 7.120,36 
SI2.636812.4 CS N°007714 - UML MODELING & DATABASE PROJECTS - CD 35.072,18 
SI2.640147.5 ORDER FORM N°1946 - RENOUVELLEMENT LICENCES KXN  2.000,00 
SI2.640202.5 ORDER FORM N°1945 - MAINTENANCE LICENCES KXN  3.000,00 
SI2.640311.5 ORDER FORM N°1979 - RENOUVELLEMENT LICENCES POUR DIVERS LOGICIELS - CD 1.000,00 
SI2.640336.3 ORDER FORM N°1980 - RENOUVELLEMENT LICENCES POUR DIVERS LOGICIELS - CD 1.331,00 
SI2.642093.1 OF N°2094 - MAINTENANCE VIDEOCONFERENCE CRISIS ROOM - FWC DI/6071 6.263,89 
SI2.637312.1 17.030600/12/637312 - WEB BASED TEXT ON SELECTED OPINION - 17.897,62 
SI2.642118.1 OF N°2092 - MAINTENANCE VIDEOCONFERENCE SYSTEM1 LUX - FWC DI/6071 6.919,30 
SI2.642123.1 OF N°2093 - MAINTENANCE VIDEOCONFERENCE SYSTEME DE CRISE 32 POINTS - FWC DI/6071 3.880,57 
SI2.642226.1 OF N°2014 - UPDATE STREAMING FACILITIES FOR SANCO SITES - CD 10.226,01 
SI2.642368.5 ORDER FORM N°1462 - DI/6650 - SERVERS FOR POLICY SYSTEMS - CD 12.000,00 
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 SI2.642368.6 ORDER FORM N°1462 - DI/6650 - SERVERS FOR POLICY SYSTEMS - CD 7.000,00 
SI2.643753.2 PURCHASE ORDER 20121218 - IT TOOL FOR THE BCP DG SANCO 510,94 
SLG.CMM.2012.16347.1 2012-16347 ORACLE BELGIUM BVBA*, CS504A,CC06030 7.513,40 
SLG.CMM.2012.16355.3 2012-16355 ORACLE BELGIUM BVBA*, CS519A,CC06030 29.365,40 
SLG.CMM.2012.16362.2 2012-16362 ORACLE BELGIUM BVBA*, CS520A,CC06030 954,60 
SLG.CMM.2012.16811.1 2012-16811 ORACLE BELGIUM BVBA*, CS505B,CC06030 4.369,48 
SLG.CMM.2012.16830.1 2012-16830 ORACLE BELGIUM BVBA*, CS519B,CC06030 8.854,80 
SLG.CMM.2012.16845.1 2012-16845 ORACLE BELGIUM BVBA*, CS506B,CC06030 1.889,66 
SLG.CMM.2012.16850.1 2012-16850 ORACLE BELGIUM BVBA*, CS507B,CC06030 1.889,66 
SI2.617249.1 17.030600 - ARCHIVAGE SITE HELP EU COM - PAIEMENT FINAL CS SI2.581153 CND 2010 13.998,00 
SI2.620330.1 17.030600/12/620330- HELP HEBERGEMENT - COMPLEMENT ENGT SI2.581153 0,00 
SI2.620330.2 17.030600/12/620330- HELP HEBERGEMENT - COMPLEMENT ENGT SI2.581153 5.991,00 
SUB-TOTAL 
 for IT SERVICES 866.375,88 
43 
 
 
 ANNEX 8 — List of service contracts — procurement (signed and committed by the CHAFEA) 
HEALTH SECURITY 
Number Acronym Title Amount 
1 
SC ON FSC EAHC/2011/CP/01 LE - 
PATIENT STUDY - LONDON 
ECONOMICS 
Impact of information on patients' choice within the context of the Directive 2011/24/EU of 
the European Parliament and of the Council on the application of patients' rights in cross 
border healthcare 
429 775,00 
2 
SC ON FSC EAHC/2012/HEALTH/01 
RFS16 TABLE TOP EXERCISE / AD1 
Inter-sectorial table top exercise on outbreak coordination and response involving public 
health and food safety authorities 
243 295,00 
3 
SC ON FSC EAHC/2012/HEALTH/01 
RFS15 TRANING SEMINARS / AD1 
The organisation of two regional training seminars with Member States public health 
authorities relating to the implementation of the new decision on serious cross-border threats 
to health 
249 599,00 
4 
SC ON FSC EAHC/2012/HEALTH/01 
LOT1 RFS18 REIMB. MEDICINAL 
PROD. 
Study on the policy mix for the reimbursement of medicinal products: proposal for a best 
practice based approach based on stakeholder assessment 
101 500,00 
5 
SC ON FSC EAHC/2010/HEALTH/01-
LOT2 / CREATIV-CEUTICAL 
External reference pricing of medicinal product simulation-based considerations for cross-
country coordination 
79 850,00 
6 
SC VACCINES - 
EAHC/2012/HEALTH/14 - DE 
ROUVROIT / AD1 
Joint procurement of vaccines - Identification of the key drivers for the vaccine industry and 
analysis of the needs of the Member States 
29 142,00 
 
Total 
 
 
1 133 161,00 
HEALTH PROMOTION 
1 ALCOHOL PREVENTION LOT 1 
(STAP) - SC 
Good practice in Member States to enhance compliance with minimum age limits for selling 
or serving alcoholic beverages 
99 995,00 
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2 ALCOHOL BEVERAGE LABELS 
LOT 2 (SIGNIFICANT) / AD1 
State of play in the use of alcoholic beverage labels to inform consumers about health aspects 99 958,00 
3 FSC EAHC/2010/HEALTH/01-LOT1 / 
MATRIX INSIGHT/AD1 
Reports on health status of the Roma population in the EU and the monitoring of the data 
collection in the area of Roma health in Member States 
99 500,00 
 
Total 
 
299 453,00 
 
HEALTH INFORMATION 
Number Acronym Title Amount 
1 EAHC/2012/HEALTH/19 EU WIDE 
ECONOMIC OVERVIEW OF THE 
MARKETS OF TISSUES AND CELLS 
FOR TRANSPLANTATION 
EU-wide economic overview of the markets of tissues and cells for transplantation 300 000,00 
2 EAHC/2012/HEALTH/11 UNDER FSC 
EAHC/2010/HEALTH/01 LOT 1 
Report on "Health and the Economic Situation in the EU 2009- 2012" 146 610,00 
3 C ON FSC EAHC/2010/HEALTH/01 
LOT 1 HEALTH REPORTS / AD1 
Implementing Framework Service contract no EAHC/2010/HEALTH/01 Lot 1 to support the 
"Health Information Strategy" for a report to identifying best practices in tobacco control to 
reduce health inequalities 
138 250,00 
4 SC ON FSC EAHC/2010/HEALTH/01-
LOT1 / NIVEL 
"Study on the feasibility and the added value of a possible 'summary information box' to be 
included in the package leaflets and the summaries of product characteristics of medicinal 
products for human use" 
63 904,00 
 
Total 
 
648 764,00 
TOTAL SERVICE CONTRACTS 2 081 378,00 
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ANNEX 9: List of other actions signed and committed by DG SANCO or sub-delegated to other DGs 
STRAND REFERENCE AMOUNT 
HEALTH SECURITY 17.030600-D3-COMITES SCIENTIFIQUES NON FOOD-SANTE PUBL-03/12->12/12 - COMPL 270.000,00 
HEALTH 
INFORMATION HARMONISATION & DEVELOPMENT OF CANCER INFORMATION  IN EU - JRC ISPRA 
4.000.000,00 
HEALTH 
INFORMATION 
SUB-DELEGATION TO SCIC  for the JOURNALIST PRIZE and the HEALTH PROGRAMME 
CONFERENCE 
102 786,14 
HEALTH 
INFORMATION 
CO-DELEGATION TO DGIT for IT Services (geographic information systems, OAS, Weblogic 
production etc.) 
353 535,10 
 
TOTAL 
 
4.726 321,24 
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